Aiping Medical: The company's anesthesia depth monitoring devices and non-invasive brain-computer interface businesses currently constitute a relatively small share of total revenue.

MetaMuskRat · 2026-03-15T21:02:02+00:00

RMB Financial News, March 13 – Aibang Medical stated on March 13 on an interactive platform that the company's anesthesia depth monitoring devices and non-invasive brain-computer interface businesses currently account for a low proportion of revenue and have minimal impact on the company's operations. The anesthesia depth monitoring device products have currently obtained 3 Class III medical device registration certificates; the electroencephalogram acquisition headband products in the multi-modal ADHD behavioral treatment system include in-hospital and home-use versions, registered as Class II medical devices; the products in the refractory insomnia anesthesia treatment system all hold medical device registration certificates. The company currently does not have a registration certificate named "brain-computer interface."

MetaMuskRat

2026-03-15 21:02:02

People’s Financial News, March 13 — Ai Peng Medical stated on the interactive platform on March 13 that the company’s anesthesia depth monitors and non-invasive brain-machine interface businesses currently account for a small proportion of revenue and have little impact on the company’s overall operations. The anesthesia depth monitor product has obtained three Class III medical device registration certificates; the multimodal ADHD behavioral treatment system’s EEG headband products, including hospital and home versions, are registered as Class II medical devices; all products in the treatment system for stubborn insomnia anesthesia have medical device registration certificates. The company currently does not have any registration certificates under the name “brain-machine interface.”

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes